202
Views
6
CrossRef citations to date
0
Altmetric
Articles

Design of new CD38 inhibitors based on CoMFA modelling and molecular docking analysis of 4‑amino-8-quinoline carboxamides and 2,4-diamino-8-quinazoline carboxamides

&
Pages 21-38 | Received 11 Sep 2018, Accepted 05 Nov 2018, Published online: 29 Nov 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Roya Ahmadi, Bakhtyar Sepehri & Raouf Ghavami. (2019) Development linear and non-linear QSAR models for predicting AXL kinase inhibitory activity of N-[4-(quinolin-4-yloxy)phenyl]benzenesulfonamides. Journal of Receptors and Signal Transduction 39:3, pages 264-275.
Read now

Articles from other publishers (3)

Roya Ahmadi, Bakhtyar Sepehri, Raouf Ghavami & Mehdi Irani. (2022) Robust and predictive QSAR models for predicting the D2, 5-HT1A, and 5-HT2A inhibition activities of fused tricyclic heterocycle piperazine (piperidine) derivatives as atypical antipsychotic drugs. Journal of Molecular Structure 1259, pages 132753.
Crossref
Bakhtyar Sepehri, Mohammad Kohnehpoushi & Raouf Ghavami. (2021) High predictive QSAR models for predicting the SARS coronavirus main protease inhibition activity of ketone-based covalent inhibitors. Journal of the Iranian Chemical Society 19:5, pages 1865-1876.
Crossref
Eric D. Boittier, Yat Yin Tang, McKenna E. Buckley, Zachariah P. Schuurs, Derek J. Richard & Neha S. Gandhi. (2020) Assessing Molecular Docking Tools to Guide Targeted Drug Discovery of CD38 Inhibitors. International Journal of Molecular Sciences 21:15, pages 5183.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.